IP Library Granted Patent US 8,728,490
Granted Patent B2
US 8,728,490 · App. 12/802,966 · Granted May 20, 2014

Patent

Inventor: Hilda Elizabeth Smith (Lelystad, NL)
Assignee: Stichting Dienst Landbouwkundig Onderzoek
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,728,490
App. No.
12/802,966
Granted
May 20, 2014
Kind
B2
Abstract

Described are Streptococcus suis infections in pigs, vaccines directed against those infections and tests for diagnosing S. suis infections. Provided is an isolated or recombinant nucleic acid encoding a capsular gene cluster of S. suis or a gene or gene fragment derived therefrom. Further provided is a nucleic acid probe or primer allowing species or serotype-specific detection of S. suis . Also provided is a Streptococcus suis antigen and vaccine derived therefrom.

Claims (15)

1. A recombinant Streptococcus suis serotype 1 knockout mutant, wherein the knockout mutation is in the capsular polysaccharide (cps) gene cluster as set forth in SEQ ID NO: 29, wherein the knockout mutation is in

the cps1E gene encoding the cps1E protein as set forth in SEQ ID NO:30,

the cps1F gene encoding the cps1F protein as set forth in SEQ ID NO:31, or

a combination thereof, and

wherein the knockout mutant is deficient in capsular expression.

2. A composition comprising the recombinant Streptococcus suis knockout mutant of claim 1 .

3. The composition of claim 2 , wherein the Streptococcus knockout mutant is able to survive in an immune-competent host.

4. The composition of claim 3 , wherein the Streptococcus knockout mutant is able to survive at least 4-5 days in the immune-competent host.

5. The composition of claim 2 , wherein the Streptococcus knockout mutant expresses a Streptococcus virulence factor or antigenic determinant.

6. The composition of claim 2 , wherein the Streptococcus knockout mutant expresses a non- Streptococcus protein.

7. The composition of claim 6 wherein the non- Streptococcus protein is from a pathogen.

8. A method for generating an immune response against a Streptococcus suis antigen in a subject, the method comprising:

inoculating the subject with the composition of claim 2 .

9. The recombinant Streptococcus knockout mutant of claim 1 that has been produced by homologous recombination.

10. The composition of claim 3 , wherein the recombinant Streptococcus knockout mutant is able to survive at least 8-10 days in the host.

Assignments (3)
CHANGE OF NAME Recorded Oct 6, 2016
From: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK
To: STICHTING WAGENINGEN RESEARCH
Reel/Frame 039959/0338 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ZIP CODE FOR THE ASSIGNEE TO 6701 BH INSTEAD OF 6701 BV (PREVIOUSLY ASSIGNMENT RECORDED ON JUNE 16, 2010 AT REEL/FRAME. 024642/0354 Recorded Dec 13, 2010
From: SMITH, HILDA ELIZABETH
To: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK
Reel/Frame 025660/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2010
From: SMITH, HILDA ELIZABETH
To: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK
Reel/Frame 024642/0354 →
Priority Claims (2)
EP 98202465 · Jul 22, 1998 · regional
EP 98202467 · Jul 22, 1998 · regional
Continuity (4)
Division 11516691 · Sep 5, 2006
Continuation 09767041 · Jan 22, 2001
Continuation PCTNL9900460 · Jul 19, 1999
Related Publication 20110171252A1 · Jul 14, 2011